140 related articles for article (PubMed ID: 9122262)
1. Irreversible antagonism of 5HT2c receptors by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ).
Ni YG; Camacho N; Miledi R
Proc Natl Acad Sci U S A; 1997 Mar; 94(6):2715-8. PubMed ID: 9122262
[TBL] [Abstract][Full Text] [Related]
2. In vitro and in vivo irreversible blockade of cortical S2 serotonin receptors by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline: a technique for investigating S2 serotonin receptor recovery.
Battaglia G; Norman AB; Newton PL; Creese I
J Neurochem; 1986 Feb; 46(2):589-93. PubMed ID: 2934516
[TBL] [Abstract][Full Text] [Related]
3. N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ) administration for studies of 5-HT1A receptor binding site inactivation and turnover.
Keck BJ; Lakoski JM
Brain Res Brain Res Protoc; 1997 Oct; 1(4):364-70. PubMed ID: 9384817
[TBL] [Abstract][Full Text] [Related]
4. N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline studies on the role of 5-HT1A and 5-HT2 receptors in mediating foot-shock-induced ultrasonic vocalisation in adult rats.
Sánchez C; Mørk A
Eur Neuropsychopharmacol; 1999 Jun; 9(4):287-94. PubMed ID: 10422888
[TBL] [Abstract][Full Text] [Related]
5. Differential effects of N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ) on various 5-HT receptor binding sites in the rat brain.
Gozlan H; Laporte AM; Thibault S; Schechter LE; Bolaños F; Hamon M
Neuropharmacology; 1994; 33(3-4):423-31. PubMed ID: 7984280
[TBL] [Abstract][Full Text] [Related]
6. Blockage of 5HT2C serotonin receptors by fluoxetine (Prozac).
Ni YG; Miledi R
Proc Natl Acad Sci U S A; 1997 Mar; 94(5):2036-40. PubMed ID: 9050900
[TBL] [Abstract][Full Text] [Related]
7. Regional heterogeneity of serotonin(1A) receptor inactivation and turnover in the aging female rat brain following EEDQ.
Keck BJ; Lakoski JM
Neuropharmacology; 2000 Apr; 39(7):1237-46. PubMed ID: 10760365
[TBL] [Abstract][Full Text] [Related]
8. Differential protection and recovery of 5-HT1A receptors from N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ) inactivation in regions of rat brain.
Vinod KY; Subhash MN; Srinivas BN
Neurochem Res; 2001 Feb; 26(2):113-20. PubMed ID: 11478737
[TBL] [Abstract][Full Text] [Related]
9. Inactivation of 5-HT1A and [3H]5-HT binding sites by N-ethoxycarbonyl-2-ethoxy-1, 2-dihydroquinoline (EEDQ) in rat brain.
Subhash MN; Srinivas BN; Vinod KY; Jagadeesh S
Neurochem Res; 1998 Oct; 23(10):1321-6. PubMed ID: 9804289
[TBL] [Abstract][Full Text] [Related]
10. Inactivation of 5-HT(1A) receptors in hippocampal and cortical homogenates.
Alper RH; Nelson DL
Eur J Pharmacol; 2000 Feb; 390(1-2):67-73. PubMed ID: 10708708
[TBL] [Abstract][Full Text] [Related]
11. In vivo estimates of efficacy at 5-HT1A receptors: effects of EEDQ on the ability of agonists to produce lower-lip retraction in rats.
Koek W; Assié MB; Zernig G; France CP
Psychopharmacology (Berl); 2000 May; 149(4):377-87. PubMed ID: 10867965
[TBL] [Abstract][Full Text] [Related]
12. Behavioral and radioligand binding evidence for irreversible dopamine receptor blockade by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline.
Hamblin MW; Creese I
Life Sci; 1983 May; 32(19):2247-55. PubMed ID: 6133202
[TBL] [Abstract][Full Text] [Related]
13. Lack of apparent receptor reserve at postsynaptic 5-hydroxytryptamine1A receptors negatively coupled to adenylyl cyclase activity in rat hippocampal membranes.
Yocca FD; Iben L; Meller E
Mol Pharmacol; 1992 Jun; 41(6):1066-72. PubMed ID: 1352034
[TBL] [Abstract][Full Text] [Related]
14. In vivo EEDQ dose-dependently inactivates rat brain 5-HT receptors but not 5-HT uptake sites.
Pinto W; Battaglia G
Neuroreport; 1993 Oct; 5(1):61-4. PubMed ID: 8280861
[TBL] [Abstract][Full Text] [Related]
15. Irreversible blockade of high-affinity choline uptake in rat brain by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ).
Vickroy TW; Malphurs WL
Biochem Pharmacol; 1994 Sep; 48(6):1281-7. PubMed ID: 7945422
[TBL] [Abstract][Full Text] [Related]
16. Region-specific serotonin1A receptor turnover following irreversible blockade with EEDQ.
Keck BJ; Lakoski JM
Neuroreport; 1996 Nov; 7(15-17):2717-21. PubMed ID: 8981454
[TBL] [Abstract][Full Text] [Related]
17. Time-course of recovery of 5-HT1A receptors and changes in 5-HT1A receptor mRNA after irreversible inactivation with EEDQ.
Raghupathi RK; Brousseau DA; McGonigle P
Brain Res Mol Brain Res; 1996 Jun; 38(2):233-42. PubMed ID: 8793111
[TBL] [Abstract][Full Text] [Related]
18. Recovery of alpha 2-adrenoceptor binding and function after irreversible inactivation by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ).
Adler CH; Meller E; Goldstein M
Eur J Pharmacol; 1985 Oct; 116(1-2):175-8. PubMed ID: 2865161
[TBL] [Abstract][Full Text] [Related]
19. Facilitation by 8-OH-DPAT of passive avoidance performance in rats after inactivation of 5-HT(1A) receptors.
Otano A; García-Osta A; Ballaz S; Frechilla D; Del Río J
Br J Pharmacol; 1999 Dec; 128(8):1691-8. PubMed ID: 10588924
[TBL] [Abstract][Full Text] [Related]
20. Effects of in vivo and in vitro treatments with N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline on putative muscarinic receptor subtypes in rat brain.
Norman AB; Creese I
Mol Pharmacol; 1986 Aug; 30(2):96-103. PubMed ID: 3755499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
